Antidote and Melanoma Research Alliance join forces to enhance clinical trial search for people impacted by melanoma

The collaboration introduces an improved patient and caregiver experience to facilitate more accurate matches to appropriate clinical trials for individuals affected by melanoma. MIAMI and WASHINGTON, March 26, 2024 /PRNewswire-PRWeb/ -- Antidote Technologies ("Antidote"), a...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news